3LEENDERS A C,DE MARIE S.The use of lipid formulation of amphotericin B for systemic fungal infectious[J].Leukemia,1996,10:1 570.
4JILL P A,RICHARD T P.Development,characterization,efficacy and mode of action of ambisome,a unilamellar liposomal formulation of amphotericin B[J].J Liposome Res,1993,3(3):429.
5National Committee for Clinical Laboratory Standards.Reference method for broth dilution antifungal susceptibility testing of yeasts:Approved standard M27-A2[S].NCCLS,2002.
6CARRILLO-MUNOZ A J,QUINDOS G,TUR C,et al.In vitro antifungal activity of liposomal nystatin in comparison with nystatin,amphotericin B cholesteryl sulphate,liposomal amphotericin B amphotericin B lipid complex,amphotericin B desoxycholate,fluconazole and itraconazole[J].J Antimicrobial of chemotherapy,1999,44:397-401.
